Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Explore blue-chip coin candidates beyond BTC/ETH and how they fit into a balanced, long-term strategy with clear evaluation criteria.
24,967 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Evernorth has filed Form S-4 as it advances a merger with Armada Acquisition Corp. II to take a Nasdaq-listed XRP tre...
Traders are flocking to Hyperliquid for round-the-clock oil trades on decentralized platforms. A JPMorgan note signal...
Analysts see SpaceX, OpenAI, and Anthropic pursuing record mega-IPOs in 2026, potentially reshaping liquidity for ven...
A federal jury found Elon Musk liable for misleading investors ahead of the Twitter acquisition. The ruling raises qu...
United Airlines will cut about 5% of capacity this quarter as jet fuel prices climb amid geopolitical tensions. The m...
Gold flirts with bear-market as risk appetite wobbles amid rising rates and Middle East tensions. Traders weigh margi...
Lumentum’s stock surged 1,000% over the past year as AI-driven demand for high-power lasers accelerates. A BNP Pariba...
Valero Energy posts a 98% capacity utilization for 2025, expands its dividend, and exits California, fueling a fresh ...
Microsoft shares fell Tuesday as investors reassessed the cost of OpenAI bets and growing capital needs, even after a...
Three top clean energy ETFs have surged more than 50% over the past year, offering divergent paths to the green trans...
Fundamental-indexing ETFs that ignore market-cap weights are drawing attention as 2026 market conditions test traditi...